📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
27
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration
15%
• Score climbed 5 points (worsening)
💹 Market Data
Market Cap$7.22M
Shares Outstanding2.29M
Float1.78M
Cash$7.35M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
7.4% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short Interest5.9K
Days to Cover1.0
% of Float0.3%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2016
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for XBIO
📊 XBIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 XBIO Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.